Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study

Elizabeth R. Plimack*, Joaquim Bellmunt, Shilpa Gupta, Raanan Berger, Laura Q.M. Chow, Jonathan Juco, Jared Lunceford, Sanatan Saraf, Rodolfo F. Perini, Peter H. O'Donnell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

294 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study'. Together they form a unique fingerprint.

Medicine & Life Sciences